Microbot Medical Inc (MBOT)

NASD · Healthcare · Medical Devices · USA

Microbot Medical Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.

Microbot Medical is a medical device company developing robotic systems for minimally invasive endovascular surgery. The FDA-cleared LIBERTY Endovascular Robotic Surgical System is a fully disposable robot designed to maneuver guidewires and catheters within the body's vasculature for peripheral vascular and interventional procedures. The company also owns the NovaCross technology for intraluminal revascularization devices.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Microbot Medical Inc stock.

Our verdict on MBOT

Undervalued: intrinsic value $0.93 per share, market price $0.69, margin of safety 25.7% (as of 2026-11-17).

A 0.6x revenue multiple, discounted for its losses, values the shares at $0.93; the price of $0.69 is 26% below that value.

ETFs with the most weight in MBOT

2 more funds hold it; the full list is part of the paid plan.

More on MBOT

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than MBOT in Medical Devices

6 more in this industry show a wider margin of safety.

Is MBOT undervalued or overvalued?

MBOT is undervalued (as of the 2026-11-17 close). A 0.6x revenue multiple, discounted for its losses, values the shares at $0.93; the price of $0.69 is 26% below that value.

What is the intrinsic value of MBOT?

$0.93 per share (as of the 2026-11-17 close), against a market price of $0.69. That is a margin of safety of 25.7%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.